Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.
Identifieur interne : 002624 ( PubMed/Corpus ); précédent : 002623; suivant : 002625Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.
Auteurs : Florence Joly ; Bénédicte Giffard ; Olivier Rigal ; Michiel B. De Ruiter ; Brent J. Small ; Martine Dubois ; Johan Lefel ; Sanne B. Schagen ; Tim A. Ahles ; Jeffrey S. Wefel ; Janette L. Vardy ; Véronique Pancré ; Marie Lange ; Hélène CastelSource :
- Journal of pain and symptom management [ 1873-6513 ] ; 2015.
English descriptors
- KwdEn :
- Animals, Antineoplastic Agents (adverse effects), Antineoplastic Agents (therapeutic use), Cognition, Cognition Disorders (diagnostic imaging), Cognition Disorders (etiology), Cognition Disorders (prevention & control), Humans, Neoplasms (diagnostic imaging), Neoplasms (psychology), Neoplasms (therapy).
- MESH :
- chemical , adverse effects : Antineoplastic Agents.
- chemical , therapeutic use : Antineoplastic Agents.
- diagnostic imaging : Cognition Disorders, Neoplasms.
- etiology : Cognition Disorders.
- prevention & control : Cognition Disorders.
- psychology : Neoplasms.
- therapy : Neoplasms.
- Animals, Cognition, Humans.
Abstract
Although cognitive impairments have been identified in patients with non-central nervous system cancer, especially breast cancer, the respective roles of cancer and therapies, and the mechanisms involved in cognitive dysfunction remain unclear.
DOI: 10.1016/j.jpainsymman.2015.06.019
PubMed: 26344551
Links to Exploration step
pubmed:26344551Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.</title><author><name sortKey="Joly, Florence" sort="Joly, Florence" uniqKey="Joly F" first="Florence" last="Joly">Florence Joly</name><affiliation><nlm:affiliation>Departments of Clinical Research Unit and Medical Oncology, Centre François Baclesse, Caen, France; CHU Côte de Nacre, Caen, France; U1086 INSERM-UCBN Cancers & Préventions, Caen, France. Electronic address: f.joly@baclesse.fr.</nlm:affiliation></affiliation></author><author><name sortKey="Giffard, Benedicte" sort="Giffard, Benedicte" uniqKey="Giffard B" first="Bénédicte" last="Giffard">Bénédicte Giffard</name><affiliation><nlm:affiliation>UMR-S1077, UNICAEN, Normandie Université, Caen, France; U1077 INSERM, Caen, France; Ecole Pratique des Hautes Etudes, UMR-S1077, Caen, France; CHU de Caen, U1077, Caen, France.</nlm:affiliation></affiliation></author><author><name sortKey="Rigal, Olivier" sort="Rigal, Olivier" uniqKey="Rigal O" first="Olivier" last="Rigal">Olivier Rigal</name><affiliation><nlm:affiliation>Service des Soins de Support and Département d'Oncologie Médicale, Centre Henri-Becquerel, Rouen, France.</nlm:affiliation></affiliation></author><author><name sortKey="De Ruiter, Michiel B" sort="De Ruiter, Michiel B" uniqKey="De Ruiter M" first="Michiel B" last="De Ruiter">Michiel B. De Ruiter</name><affiliation><nlm:affiliation>Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; School of Aging Studies, University of South Florida, Tampa, Florida, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Small, Brent J" sort="Small, Brent J" uniqKey="Small B" first="Brent J" last="Small">Brent J. Small</name><affiliation><nlm:affiliation>School of Aging Studies, University of South Florida, Tampa, Florida, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Dubois, Martine" sort="Dubois, Martine" uniqKey="Dubois M" first="Martine" last="Dubois">Martine Dubois</name><affiliation><nlm:affiliation>INSERM U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation, DC2N, Astrocyte and Vascular Niche, Biomedical Research Institute (IRIB), University of Rouen, Mont-Saint-Aignan, France.</nlm:affiliation></affiliation></author><author><name sortKey="Lefel, Johan" sort="Lefel, Johan" uniqKey="Lefel J" first="Johan" last="Lefel">Johan Lefel</name><affiliation><nlm:affiliation>Service des Soins de Support and Département d'Oncologie Médicale, Centre Henri-Becquerel, Rouen, France.</nlm:affiliation></affiliation></author><author><name sortKey="Schagen, Sanne B" sort="Schagen, Sanne B" uniqKey="Schagen S" first="Sanne B" last="Schagen">Sanne B. Schagen</name><affiliation><nlm:affiliation>Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Ahles, Tim A" sort="Ahles, Tim A" uniqKey="Ahles T" first="Tim A" last="Ahles">Tim A. Ahles</name><affiliation><nlm:affiliation>Neurology Service, Memorial Sloan-Kettering Cancer Center, and Weill Medical College of Cornell University, New York, New York, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Wefel, Jeffrey S" sort="Wefel, Jeffrey S" uniqKey="Wefel J" first="Jeffrey S" last="Wefel">Jeffrey S. Wefel</name><affiliation><nlm:affiliation>Section of Neuropsychology, Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Vardy, Janette L" sort="Vardy, Janette L" uniqKey="Vardy J" first="Janette L" last="Vardy">Janette L. Vardy</name><affiliation><nlm:affiliation>University of Sydney, Sydney, and Concord Cancer Centre, Concord Hospital, Concord, New South Wales, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Pancre, Veronique" sort="Pancre, Veronique" uniqKey="Pancre V" first="Véronique" last="Pancré">Véronique Pancré</name><affiliation><nlm:affiliation>NorthWest Canceropole, CNRS-UMR 8161-Institut de Biologie de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Lange, Marie" sort="Lange, Marie" uniqKey="Lange M" first="Marie" last="Lange">Marie Lange</name><affiliation><nlm:affiliation>Departments of Clinical Research Unit and Medical Oncology, Centre François Baclesse, Caen, France; U1086 INSERM-UCBN Cancers & Préventions, Caen, France.</nlm:affiliation></affiliation></author><author><name sortKey="Castel, Helene" sort="Castel, Helene" uniqKey="Castel H" first="Hélène" last="Castel">Hélène Castel</name><affiliation><nlm:affiliation>INSERM U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation, DC2N, Astrocyte and Vascular Niche, Biomedical Research Institute (IRIB), University of Rouen, Mont-Saint-Aignan, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26344551</idno><idno type="pmid">26344551</idno><idno type="doi">10.1016/j.jpainsymman.2015.06.019</idno><idno type="wicri:Area/PubMed/Corpus">002624</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002624</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.</title><author><name sortKey="Joly, Florence" sort="Joly, Florence" uniqKey="Joly F" first="Florence" last="Joly">Florence Joly</name><affiliation><nlm:affiliation>Departments of Clinical Research Unit and Medical Oncology, Centre François Baclesse, Caen, France; CHU Côte de Nacre, Caen, France; U1086 INSERM-UCBN Cancers & Préventions, Caen, France. Electronic address: f.joly@baclesse.fr.</nlm:affiliation></affiliation></author><author><name sortKey="Giffard, Benedicte" sort="Giffard, Benedicte" uniqKey="Giffard B" first="Bénédicte" last="Giffard">Bénédicte Giffard</name><affiliation><nlm:affiliation>UMR-S1077, UNICAEN, Normandie Université, Caen, France; U1077 INSERM, Caen, France; Ecole Pratique des Hautes Etudes, UMR-S1077, Caen, France; CHU de Caen, U1077, Caen, France.</nlm:affiliation></affiliation></author><author><name sortKey="Rigal, Olivier" sort="Rigal, Olivier" uniqKey="Rigal O" first="Olivier" last="Rigal">Olivier Rigal</name><affiliation><nlm:affiliation>Service des Soins de Support and Département d'Oncologie Médicale, Centre Henri-Becquerel, Rouen, France.</nlm:affiliation></affiliation></author><author><name sortKey="De Ruiter, Michiel B" sort="De Ruiter, Michiel B" uniqKey="De Ruiter M" first="Michiel B" last="De Ruiter">Michiel B. De Ruiter</name><affiliation><nlm:affiliation>Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; School of Aging Studies, University of South Florida, Tampa, Florida, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Small, Brent J" sort="Small, Brent J" uniqKey="Small B" first="Brent J" last="Small">Brent J. Small</name><affiliation><nlm:affiliation>School of Aging Studies, University of South Florida, Tampa, Florida, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Dubois, Martine" sort="Dubois, Martine" uniqKey="Dubois M" first="Martine" last="Dubois">Martine Dubois</name><affiliation><nlm:affiliation>INSERM U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation, DC2N, Astrocyte and Vascular Niche, Biomedical Research Institute (IRIB), University of Rouen, Mont-Saint-Aignan, France.</nlm:affiliation></affiliation></author><author><name sortKey="Lefel, Johan" sort="Lefel, Johan" uniqKey="Lefel J" first="Johan" last="Lefel">Johan Lefel</name><affiliation><nlm:affiliation>Service des Soins de Support and Département d'Oncologie Médicale, Centre Henri-Becquerel, Rouen, France.</nlm:affiliation></affiliation></author><author><name sortKey="Schagen, Sanne B" sort="Schagen, Sanne B" uniqKey="Schagen S" first="Sanne B" last="Schagen">Sanne B. Schagen</name><affiliation><nlm:affiliation>Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Ahles, Tim A" sort="Ahles, Tim A" uniqKey="Ahles T" first="Tim A" last="Ahles">Tim A. Ahles</name><affiliation><nlm:affiliation>Neurology Service, Memorial Sloan-Kettering Cancer Center, and Weill Medical College of Cornell University, New York, New York, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Wefel, Jeffrey S" sort="Wefel, Jeffrey S" uniqKey="Wefel J" first="Jeffrey S" last="Wefel">Jeffrey S. Wefel</name><affiliation><nlm:affiliation>Section of Neuropsychology, Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Vardy, Janette L" sort="Vardy, Janette L" uniqKey="Vardy J" first="Janette L" last="Vardy">Janette L. Vardy</name><affiliation><nlm:affiliation>University of Sydney, Sydney, and Concord Cancer Centre, Concord Hospital, Concord, New South Wales, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Pancre, Veronique" sort="Pancre, Veronique" uniqKey="Pancre V" first="Véronique" last="Pancré">Véronique Pancré</name><affiliation><nlm:affiliation>NorthWest Canceropole, CNRS-UMR 8161-Institut de Biologie de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Lange, Marie" sort="Lange, Marie" uniqKey="Lange M" first="Marie" last="Lange">Marie Lange</name><affiliation><nlm:affiliation>Departments of Clinical Research Unit and Medical Oncology, Centre François Baclesse, Caen, France; U1086 INSERM-UCBN Cancers & Préventions, Caen, France.</nlm:affiliation></affiliation></author><author><name sortKey="Castel, Helene" sort="Castel, Helene" uniqKey="Castel H" first="Hélène" last="Castel">Hélène Castel</name><affiliation><nlm:affiliation>INSERM U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation, DC2N, Astrocyte and Vascular Niche, Biomedical Research Institute (IRIB), University of Rouen, Mont-Saint-Aignan, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of pain and symptom management</title><idno type="eISSN">1873-6513</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antineoplastic Agents (adverse effects)</term><term>Antineoplastic Agents (therapeutic use)</term><term>Cognition</term><term>Cognition Disorders (diagnostic imaging)</term><term>Cognition Disorders (etiology)</term><term>Cognition Disorders (prevention & control)</term><term>Humans</term><term>Neoplasms (diagnostic imaging)</term><term>Neoplasms (psychology)</term><term>Neoplasms (therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Cognition Disorders</term><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cognition Disorders</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Cognition Disorders</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cognition</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Although cognitive impairments have been identified in patients with non-central nervous system cancer, especially breast cancer, the respective roles of cancer and therapies, and the mechanisms involved in cognitive dysfunction remain unclear.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26344551</PMID><DateCreated><Year>2015</Year><Month>11</Month><Day>30</Day></DateCreated><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6513</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of pain and symptom management</Title><ISOAbbreviation>J Pain Symptom Manage</ISOAbbreviation></Journal><ArticleTitle>Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.</ArticleTitle><Pagination><MedlinePgn>830-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpainsymman.2015.06.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0885-3924(15)00451-0</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Although cognitive impairments have been identified in patients with non-central nervous system cancer, especially breast cancer, the respective roles of cancer and therapies, and the mechanisms involved in cognitive dysfunction remain unclear.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To report a state-of-the-art update from the International Cognitive and Cancer Task Force conference held in 2012.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A report of the meeting and recent new perspectives are presented.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Recent clinical data support that non-central nervous system cancer per se may be involved in cognitive dysfunctions associated with inflammation parameters. The role of chemotherapy on cognitive decline was confirmed in colorectal and testicular cancers. Whereas the impact of hormone therapy remains debatable, some studies support a negative impact of targeted therapies on cognition. Regarding interventions, preliminary results of cognitive rehabilitation showed encouraging results. The methodology of future longitudinal studies has to be optimized by a priori end points, the use of validated test batteries, and the inclusion of control groups. Comorbidities and aging are important factors to be taken into account in future studies. Preclinical studies in animal models highlighted the role of cancer itself on cognition and support the possible benefits of prevention/care during chemotherapy. Progress in neuroimaging will help specify neural processes affected by treatments.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Clinical data and animal models confirmed that chemotherapy induces direct cognitive deficit. The benefits of cognitive rehabilitation are still to be confirmed. Studies evaluating the mechanisms underlying cognitive impairments using advanced neuroimaging techniques integrating the evaluation of genetic factors are ongoing.</AbstractText><CopyrightInformation>Copyright © 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joly</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Departments of Clinical Research Unit and Medical Oncology, Centre François Baclesse, Caen, France; CHU Côte de Nacre, Caen, France; U1086 INSERM-UCBN Cancers & Préventions, Caen, France. Electronic address: f.joly@baclesse.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giffard</LastName><ForeName>Bénédicte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>UMR-S1077, UNICAEN, Normandie Université, Caen, France; U1077 INSERM, Caen, France; Ecole Pratique des Hautes Etudes, UMR-S1077, Caen, France; CHU de Caen, U1077, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigal</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Service des Soins de Support and Département d'Oncologie Médicale, Centre Henri-Becquerel, Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Ruiter</LastName><ForeName>Michiel B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; School of Aging Studies, University of South Florida, Tampa, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Small</LastName><ForeName>Brent J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>School of Aging Studies, University of South Florida, Tampa, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubois</LastName><ForeName>Martine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>INSERM U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation, DC2N, Astrocyte and Vascular Niche, Biomedical Research Institute (IRIB), University of Rouen, Mont-Saint-Aignan, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LeFel</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Service des Soins de Support and Département d'Oncologie Médicale, Centre Henri-Becquerel, Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schagen</LastName><ForeName>Sanne B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahles</LastName><ForeName>Tim A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Neurology Service, Memorial Sloan-Kettering Cancer Center, and Weill Medical College of Cornell University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wefel</LastName><ForeName>Jeffrey S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Section of Neuropsychology, Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vardy</LastName><ForeName>Janette L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>University of Sydney, Sydney, and Concord Cancer Centre, Concord Hospital, Concord, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pancré</LastName><ForeName>Véronique</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>NorthWest Canceropole, CNRS-UMR 8161-Institut de Biologie de Lille, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departments of Clinical Research Unit and Medical Oncology, Centre François Baclesse, Caen, France; U1086 INSERM-UCBN Cancers & Préventions, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castel</LastName><ForeName>Hélène</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>INSERM U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation, DC2N, Astrocyte and Vascular Niche, Biomedical Research Institute (IRIB), University of Rouen, Mont-Saint-Aignan, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pain Symptom Manage</MedlineTA><NlmUniqueID>8605836</NlmUniqueID><ISSNLinking>0885-3924</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="Y">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cancer</Keyword><Keyword MajorTopicYN="N">chemotherapy</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">neuroimaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>04</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>07</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26344551</ArticleId><ArticleId IdType="pii">S0885-3924(15)00451-0</ArticleId><ArticleId IdType="doi">10.1016/j.jpainsymman.2015.06.019</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002624 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002624 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26344551
|texte= Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26344551" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |